
Opinion|Videos|December 15, 2023
Teaser: Examining the Role of a Novel Class of Medications for the Management of Multiple Sclerosis
Advertisement
Episodes in this series

Now Playing
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Cefdinir Nearly Doubles Outpatient Uncomplicated UTI Treatment Failure Compared With Cephalexin
2
Stronger Carer-Child Bonds Don’t Predict Later Mental Health
3
FDA to Remove Black Box Warnings From HRT, Debate Ensues
4
Five Ways AI Is Transforming Cancer Care—and Companies That Are Making It Happen
5















































